Cutaneous adverse drug reactions to fixed-dose combination treatments for TB

Affiliations

¹ North Central London Tuberculosis Service, Whittington Hospital NHS Trust, London, UK.
² Department of Respiratory Medicine, University College London, Royal Free Campus, London, 6UCL Respiratory, University College London, London, UK.
³ Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, University College London, Royal Free Campus, London, 6UCL Respiratory, University College London, London, UK.
⁴ Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK, Institute of Immunity and Transplantation, University College London, Royal Free Campus, London, UK.
⁵ Department of Respiratory Medicine, University College London, Royal Free Campus, London, 6UCL Respiratory, University College London, London, UK, UCL Respiratory, University College London, London, UK.

E McCormick et al. Int J Tuberc Lung Dis. 2022.

. 2022 Sep 1;26(9):886-887.

doi: 10.5588/ijtld.22.0202.

¹ North Central London Tuberculosis Service, Whittington Hospital NHS Trust, London, UK.
² Department of Respiratory Medicine, University College London, Royal Free Campus, London, 6UCL Respiratory, University College London, London, UK.
³ Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, University College London, Royal Free Campus, London, 6UCL Respiratory, University College London, London, UK.
⁴ Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK, Institute of Immunity and Transplantation, University College London, Royal Free Campus, London, UK.
⁵ Department of Respiratory Medicine, University College London, Royal Free Campus, London, 6UCL Respiratory, University College London, London, UK, UCL Respiratory, University College London, London, UK.

No abstract available

Publication types